1-aminoindan has been researched along with rasagiline in 3 studies
Studies (1-aminoindan) | Trials (1-aminoindan) | Recent Studies (post-2010) (1-aminoindan) | Studies (rasagiline) | Trials (rasagiline) | Recent Studies (post-2010) (rasagiline) |
---|---|---|---|---|---|
18 | 0 | 8 | 535 | 72 | 314 |
Protein | Taxonomy | 1-aminoindan (IC50) | rasagiline (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 2.3865 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 1.0029 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.2115 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.088 | |
Acetylcholinesterase | Homo sapiens (human) | 0.019 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.2217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balogh, B; Chai, CL; Chua, YY; Deme, R; Gölöncsér, F; Ho, HK; Huleatt, PB; Khoo, ML; Liew, RS; Magyar, K; Mátyus, P; Sheela, DP; Sperlágh, B; Tan, TW | 1 |
Dimpfel, W; Hoffmann, JA | 1 |
Kakish, J; Lee, JS; Tavassoly, O | 1 |
3 other study(ies) available for 1-aminoindan and rasagiline
Article | Year |
---|---|
Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Pargyline; Parkinson Disease; PC12 Cells; Propylamines; Rats; Structure-Activity Relationship | 2015 |
Electropharmacograms of rasagiline, its metabolite aminoindan and selegiline in the freely moving rat.
Topics: Animals; Brain Waves; Dose-Response Relationship, Drug; Indans; Monoamine Oxidase Inhibitors; Rats; Rats, Inbred F344; Selegiline | 2010 |
Rasagiline, a suicide inhibitor of monoamine oxidases, binds reversibly to α-synuclein.
Topics: alpha-Synuclein; Calorimetry; Indans; Methamphetamine; Monoamine Oxidase Inhibitors; Nanopores; Neuroprotective Agents; Protein Binding; Selegiline | 2015 |